Logo image of CLNE

CLEAN ENERGY FUELS CORP (CLNE) Stock Fundamental Analysis

NASDAQ:CLNE - Nasdaq - US1844991018 - Common Stock - Currency: USD

2.1  -0.06 (-2.78%)

After market: 2.14 +0.04 (+1.9%)

Fundamental Rating

4

Overall CLNE gets a fundamental rating of 4 out of 10. We evaluated CLNE against 210 industry peers in the Oil, Gas & Consumable Fuels industry. The financial health of CLNE is average, but there are quite some concerns on its profitability. CLNE shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year CLNE was profitable.
CLNE had a positive operating cash flow in the past year.
CLNE had negative earnings in each of the past 5 years.
In the past 5 years CLNE always reported a positive cash flow from operatings.
CLNE Yearly Net Income VS EBIT VS OCF VS FCFCLNE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

CLNE has a Return On Assets of -17.88%. This is amonst the worse of the industry: CLNE underperforms 90.00% of its industry peers.
The Return On Equity of CLNE (-33.45%) is worse than 82.38% of its industry peers.
Industry RankSector Rank
ROA -17.88%
ROE -33.45%
ROIC N/A
ROA(3y)-6.67%
ROA(5y)-6.22%
ROE(3y)-11.16%
ROE(5y)-9.58%
ROIC(3y)N/A
ROIC(5y)N/A
CLNE Yearly ROA, ROE, ROICCLNE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30 -40

1.3 Margins

CLNE has a Gross Margin (30.77%) which is in line with its industry peers.
In the last couple of years the Gross Margin of CLNE has declined.
The Profit Margin and Operating Margin are not available for CLNE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 30.77%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y25.4%
GM growth 5Y-4.26%
CLNE Yearly Profit, Operating, Gross MarginsCLNE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

5

2. Health

2.1 Basic Checks

CLNE does not have a ROIC to compare to the WACC, probably because it is not profitable.
CLNE has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for CLNE has been increased compared to 5 years ago.
Compared to 1 year ago, CLNE has a worse debt to assets ratio.
CLNE Yearly Shares OutstandingCLNE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CLNE Yearly Total Debt VS Total AssetsCLNE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

CLNE has an Altman-Z score of -0.47. This is a bad value and indicates that CLNE is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of CLNE (-0.47) is worse than 71.90% of its industry peers.
CLNE has a debt to FCF ratio of 46.58. This is a negative value and a sign of low solvency as CLNE would need 46.58 years to pay back of all of its debts.
CLNE's Debt to FCF ratio of 46.58 is in line compared to the rest of the industry. CLNE outperforms 41.90% of its industry peers.
A Debt/Equity ratio of 0.46 indicates that CLNE is not too dependend on debt financing.
CLNE has a Debt to Equity ratio of 0.46. This is comparable to the rest of the industry: CLNE outperforms 50.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF 46.58
Altman-Z -0.47
ROIC/WACCN/A
WACC10.27%
CLNE Yearly LT Debt VS Equity VS FCFCLNE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

CLNE has a Current Ratio of 2.82. This indicates that CLNE is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 2.82, CLNE belongs to the best of the industry, outperforming 84.29% of the companies in the same industry.
CLNE has a Quick Ratio of 2.50. This indicates that CLNE is financially healthy and has no problem in meeting its short term obligations.
CLNE has a Quick ratio of 2.50. This is amongst the best in the industry. CLNE outperforms 84.29% of its industry peers.
Industry RankSector Rank
Current Ratio 2.82
Quick Ratio 2.5
CLNE Yearly Current Assets VS Current LiabilitesCLNE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

7

3. Growth

3.1 Past

CLNE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 166.67%, which is quite impressive.
CLNE shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -21.00% yearly.
The Revenue has been growing slightly by 4.85% in the past year.
CLNE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.86% yearly.
EPS 1Y (TTM)166.67%
EPS 3Y58.74%
EPS 5Y-21%
EPS Q2Q%200%
Revenue 1Y (TTM)4.85%
Revenue growth 3Y17.62%
Revenue growth 5Y3.86%
Sales Q2Q%0.05%

3.2 Future

CLNE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 35.63% yearly.
Based on estimates for the next years, CLNE will show a very strong growth in Revenue. The Revenue will grow by 22.46% on average per year.
EPS Next Y-564.1%
EPS Next 2Y-102.47%
EPS Next 3Y-45.89%
EPS Next 5Y35.63%
Revenue Next Year2.76%
Revenue Next 2Y6.02%
Revenue Next 3Y6.94%
Revenue Next 5Y22.46%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CLNE Yearly Revenue VS EstimatesCLNE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M 800M 1B
CLNE Yearly EPS VS EstimatesCLNE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 -0.2 -0.4 -0.6 -0.8 -1

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 35.00, which means the current valuation is very expensive for CLNE.
63.81% of the companies in the same industry are cheaper than CLNE, based on the Price/Earnings ratio.
CLNE is valuated rather expensively when we compare the Price/Earnings ratio to 28.04, which is the current average of the S&P500 Index.
CLNE is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 35
Fwd PE N/A
CLNE Price Earnings VS Forward Price EarningsCLNE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CLNE is valued a bit more expensive than the industry average as 70.00% of the companies are valued more cheaply.
The rest of the industry has a similar Price/Free Cash Flow ratio as CLNE.
Industry RankSector Rank
P/FCF 78.83
EV/EBITDA 27.96
CLNE Per share dataCLNE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

CLNE's earnings are expected to decrease with -45.89% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-102.47%
EPS Next 3Y-45.89%

0

5. Dividend

5.1 Amount

No dividends for CLNE!.
Industry RankSector Rank
Dividend Yield N/A

CLEAN ENERGY FUELS CORP

NASDAQ:CLNE (7/25/2025, 8:00:00 PM)

After market: 2.14 +0.04 (+1.9%)

2.1

-0.06 (-2.78%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)05-08 2025-05-08/amc
Earnings (Next)08-07 2025-08-07/amc
Inst Owners49.9%
Inst Owner Change-0.02%
Ins Owners1.14%
Ins Owner Change0.99%
Market Cap464.06M
Analysts84
Price Target4.33 (106.19%)
Short Float %5.18%
Short Ratio2.99
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)145.02%
Min EPS beat(2)106%
Max EPS beat(2)184.05%
EPS beat(4)4
Avg EPS beat(4)151.1%
Min EPS beat(4)106%
Max EPS beat(4)185.77%
EPS beat(8)8
Avg EPS beat(8)152.93%
EPS beat(12)11
Avg EPS beat(12)112.95%
EPS beat(16)12
Avg EPS beat(16)138.84%
Revenue beat(2)2
Avg Revenue beat(2)4.14%
Min Revenue beat(2)3.83%
Max Revenue beat(2)4.45%
Revenue beat(4)3
Avg Revenue beat(4)0.14%
Min Revenue beat(4)-9.94%
Max Revenue beat(4)4.45%
Revenue beat(8)4
Avg Revenue beat(8)-2.73%
Revenue beat(12)6
Avg Revenue beat(12)-0.34%
Revenue beat(16)7
Avg Revenue beat(16)-7.25%
PT rev (1m)0%
PT rev (3m)-36.7%
EPS NQ rev (1m)0%
EPS NQ rev (3m)20.9%
EPS NY rev (1m)0%
EPS NY rev (3m)56.05%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.73%
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.16%
Valuation
Industry RankSector Rank
PE 35
Fwd PE N/A
P/S 1.12
P/FCF 78.83
P/OCF 5.43
P/B 0.78
P/tB 0.78
EV/EBITDA 27.96
EPS(TTM)0.06
EY2.86%
EPS(NY)-0.08
Fwd EYN/A
FCF(TTM)0.03
FCFY1.27%
OCF(TTM)0.39
OCFY18.41%
SpS1.88
BVpS2.7
TBVpS2.68
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -17.88%
ROE -33.45%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 30.77%
FCFM 1.42%
ROA(3y)-6.67%
ROA(5y)-6.22%
ROE(3y)-11.16%
ROE(5y)-9.58%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y25.4%
GM growth 5Y-4.26%
F-Score5
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF 46.58
Debt/EBITDA 18.32
Cap/Depr 83%
Cap/Sales 19.12%
Interest Coverage N/A
Cash Conversion 572.81%
Profit Quality N/A
Current Ratio 2.82
Quick Ratio 2.5
Altman-Z -0.47
F-Score5
WACC10.27%
ROIC/WACCN/A
Cap/Depr(3y)180.71%
Cap/Depr(5y)126.79%
Cap/Sales(3y)20.16%
Cap/Sales(5y)15.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)166.67%
EPS 3Y58.74%
EPS 5Y-21%
EPS Q2Q%200%
EPS Next Y-564.1%
EPS Next 2Y-102.47%
EPS Next 3Y-45.89%
EPS Next 5Y35.63%
Revenue 1Y (TTM)4.85%
Revenue growth 3Y17.62%
Revenue growth 5Y3.86%
Sales Q2Q%0.05%
Revenue Next Year2.76%
Revenue Next 2Y6.02%
Revenue Next 3Y6.94%
Revenue Next 5Y22.46%
EBIT growth 1Y-60.6%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year236.76%
EBIT Next 3Y65.59%
EBIT Next 5Y46.27%
FCF growth 1Y122.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y99.15%
OCF growth 3Y16.07%
OCF growth 5Y39.37%